$114.69
+0.09 (+0.08%)
Performance
1D
—
1W
—
1M
—
3M
+74.54%
6M
+43.81%
1Y
+58.94%
YTD
+81.07%
Open$114.68
Previous Close$114.60
Day High$114.72
Day Low$114.39
52W High$94.07
52W Low$47.86
Volume—
Avg Volume745.8K
Market Cap3.85B
P/E Ratio—
EPS$-3.92
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$67.56
Above
SMA 200
$71.93
Above
RSI (14)
44.8
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Hold
24 analysts
Price Target
-15.5% upside
Current
$114.69
$114.69
Target
$96.95
$96.95
$73.10
$96.95 avg
$131.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 120.18M | 2.26B | 2.06B |
| Net Income | -119,524,022 | 113.46M | 99.51M |
| Profit Margin | -99.5% | 5.0% | 4.8% |
| EBITDA | -147,401,032 | 251.62M | 213.71M |
| Free Cash Flow | — | 62.68M | 52.56M |
| Rev Growth | — | +18.8% | +20.4% |
| Debt/Equity | 0.00 | 0.80 | 0.97 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |